Freestone Capital Holdings, LLC Bio N Tech Se Transaction History
Freestone Capital Holdings, LLC
- $3.3 Billion
- Q4 2025
A detailed history of Freestone Capital Holdings, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 7,914 shares of BNTX stock, worth $815,854. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,914Holding current value
$815,854% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
319Shares Held
37.1MCall Options Held
1.15MPut Options Held
1.36M-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.83MShares$498 Million0.29% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$436 Million1.69% of portfolio
-
Primecap Management CO Pasadena, CA3.87MShares$399 Million0.3% of portfolio
-
Dodge & Cox San Francisco, CA3.65MShares$376 Million0.21% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$195 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...